RarePipelinepeopleInnovationCollaborationCareersFinance Advance treatment
Hansa Biopharma
HNSA (, %) SEK
Hansa Biopharma
Evenemang

Investerarrelationer Kontakt

Investor Relations

Klaus Sindahl

Head of Investor Relations

Mobilnummer: +46 (0) 709 298 269

E-mail: klaus.sindahl@hansabiopharma.com